Rogers Corp (ROG)

Trade ROG now with
9/17/2018 4:30:53 PM Rogers Corp Appoints Michael Ludwig As CFO
9/6/2018 1:03:50 AM Genentech To Present New Data From Extensive Lung Cancer Program At 2018 WCLC
8/23/2018 7:01:32 AM Roche Gets FDA Approval For Cobas EGFR Mutation Test V2 As Companion Diagnostic With IRESSA
8/13/2018 1:01:55 AM Genentech :FDA Grants Breakthrough Therapy Designation For Xolair For Food Allergies
7/31/2018 4:11:05 PM Rogers Reports Q2 EPS Of $0.93 Vs. $1.13 Last Year
7/30/2018 10:00:56 AM Roche's Cobas HPV Test Gets FDA Approval For First-line Cervical Cancer Screening Using SurePath Preservative Fluid
7/20/2018 1:04:07 AM Genentech To Present 16 New Data Presentations Across Alzheimer’s Disease (AD) Pipeline At AAIC
7/19/2018 1:01:29 AM Genentech Says Phase III IMpower132 Study Met Its Co-primary Endpoint Of Progression-free Survival
7/18/2018 1:00:49 AM Genentech Says FDA Grants Breakthrough Therapy Designation For TECENTRIQ In Combination With Avastin
7/17/2018 1:02:23 AM Genentech Says Phase III CAPSTONE-2 Study Assessing Safety And Efficacy Of Baloxavir Marboxil Meets Primary Objective
7/12/2018 1:03:02 AM Genentech Announces Submission Of Supplemental New Drug Application For Venclexta
7/9/2018 10:04:09 AM Rogers Acquires Griswold; Deal Expected To Be Accretive To 2019 EPS
7/2/2018 1:02:33 AM Genentech Says Phase III IMpassion130 Study Meets Co-primary Endpoint Of Progression Free Survival
6/26/2018 2:03:41 AM Genentech Says FDA Granted Priority Review To Baloxavir Marboxil For Treatment Of Influenza
6/25/2018 1:01:49 AM Genentech Says Phase III IMpower133 Study Meets Co-primary Endpoints Of Overall Survival And PFS
6/19/2018 7:03:21 AM University Of Missouri School Of Medicine, Roche Collaborate On First US Implementation Of Tumor Board Software
6/14/2018 1:02:13 AM Genentech Announces New OCREVUS Data On Long-Term Disability Benefits In Primary Progressive Multiple Sclerosis
6/11/2018 7:02:03 AM Roche Announces Plans To Launch The CoaguChek Vantus System
6/8/2018 3:09:15 PM Genentech Gets FDA Approval For Venclexta Plus Rituxan For People With Previously Treated Chronic Lymphocytic Leukemia
6/7/2018 8:42:08 AM Roche To Showcase New Solutions To Consolidate Automated Molecular Testing, Microbiology Topics At ASM Microbe 2018